Brian K Link Selected Research

Brian K Link Research Topics

Disease

34	Lymphoma (Lymphomas) 06/2024 - 02/2002
31	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 11/2023 - 10/2007
22	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2019 - 02/2002
21	Neoplasms (Cancer) 01/2024 - 02/2002
17	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2021 - 03/2010
10	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 12/2017 - 03/2005
8	Hodgkin Disease (Hodgkin's Disease) 01/2020 - 04/2006
6	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022 - 03/2004
4	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 12/2023 - 11/2013
4	Neutropenia 01/2011 - 05/2005
3	Infections 01/2016 - 10/2010
2	Fatigue 01/2022 - 03/2012
2	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 04/2020 - 12/2010
2	Leukemia 01/2020 - 04/2008
2	Hematologic Neoplasms (Hematological Malignancy) 11/2017 - 01/2016
2	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2016 - 05/2015
2	Febrile Neutropenia 04/2006 - 03/2003
1	Disease Progression 01/2023
1	Herpes Zoster 12/2022
1	Chronic Disease (Chronic Diseases) 01/2022
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2022
1	IgA Deficiency 11/2020
1	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2020
1	Autoimmune Diseases (Autoimmune Disease) 10/2019
1	Inflammation (Inflammations) 10/2019
1	Testicular Neoplasms (Testicular Cancer) 01/2018
1	Follicular Mucinosis 04/2017
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2017
1	Necrosis 01/2017
1	Agammaglobulinemia (Hypogammaglobulinemia) 01/2016
1	Multiple Myeloma 01/2016
1	Urinary Bladder Neoplasms (Bladder Cancer) 12/2015

Drug/Important Bio-Agent (IBA)

28	Rituximab (Mabthera)FDA Link 12/2022 - 02/2002
10	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 03/2003
9	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020 - 03/2003
9	Vincristine (Oncovin)FDA LinkGeneric 01/2020 - 03/2003
9	Prednisone (Sone)FDA LinkGeneric 01/2020 - 03/2003
8	Monoclonal AntibodiesIBA 01/2015 - 02/2002
7	AnthracyclinesIBA 01/2019 - 06/2010
6	CytokinesIBA 08/2017 - 12/2012
5	ProMune (CpG 7909)IBA 07/2013 - 09/2006
4	AntigensIBA 10/2019 - 02/2002
4	Complement System Proteins (Complement)IBA 02/2017 - 06/2008
3	Dihydrotachysterol (AT 10)IBA 01/2022 - 10/2019
3	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 10/2019 - 06/2008
3	Vitamin D FDA LinkGeneric 11/2017 - 09/2010
3	Immunoglobulins (Immunoglobulin)IBA 12/2014 - 12/2011
3	OligodeoxyribonucleotidesIBA 07/2013 - 03/2005
3	Bleomycin (Blenoxane)FDA LinkGeneric 05/2012 - 04/2006
3	Vinblastine (Vinblastine Sulfate)FDA Link 05/2012 - 04/2006
3	Dacarbazine (DIC)FDA LinkGeneric 05/2012 - 04/2006
3	CPG-oligonucleotideIBA 02/2012 - 03/2005
3	epratuzumabIBA 10/2011 - 02/2002
2	Biological FactorsIBA 01/2024 - 09/2012
2	Alkylating AgentsIBA 11/2023 - 04/2022
2	Bendamustine Hydrochloride FDA Link 12/2022 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2017
2	Etoposide (VP 16)FDA LinkGeneric 01/2020 - 11/2017
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2018 - 10/2014
2	fludarabineIBA 05/2015 - 10/2010
2	ocaratuzumabIBA 01/2015 - 03/2012
2	Alemtuzumab (Campath)FDA Link 07/2014 - 10/2010
2	ofatumumab FDA Link 04/2012 - 06/2008
2	hydroxide ionIBA 02/2011 - 09/2010
2	Toll-Like Receptor 9IBA 12/2010 - 10/2007
2	Immunoconjugates (Immunoconjugate)IBA 02/2002 - 02/2002
2	Humanized Monoclonal AntibodiesIBA 02/2002 - 02/2002
2	apolizumabIBA 02/2002 - 02/2002
1	tisagenlecleucelIBA 11/2022
1	Chimeric Antigen ReceptorsIBA 11/2022
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Immunoglobulin E (IgE)IBA 11/2020
1	ORALIT (ORS)IBA 01/2020
1	Hemoglobins (Hemoglobin)IBA 01/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019
1	lipid-associated sialic acid (LASA)IBA 12/2018
1	Formaldehyde (Formol)FDA Link 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	ParaffinIBA 01/2018
1	CalciumIBA 11/2017
1	ElementsIBA 04/2017
1	obinutuzumabIBA 02/2017
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2016
1	RNA (Ribonucleic Acid)IBA 01/2016
1	cyclo(Arg-Pro) (CI 4)IBA 12/2015
1	Transcription Factors (Transcription Factor)IBA 05/2015
1	ChemokinesIBA 02/2015
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 02/2015
1	purineIBA 07/2014

Therapy/Procedure

45	Therapeutics 12/2023 - 03/2003
19	Drug Therapy (Chemotherapy) 06/2024 - 03/2003
6	Immunotherapy 06/2024 - 02/2002
1	Retreatment 01/2022
1	Cell Transplantation 01/2022
1	Aftercare (After-Treatment) 04/2020
1	Secondary Prevention 01/2018
1	Induction Chemotherapy 01/2018
1	Autologous Transplantation 01/2018
1	Stem Cell Transplantation 10/2017
1	Breast Implants (Breast Implant) 01/2017